-
Prospects and Challenges of Chitosan-Based Drug Carriers for Anticancer Agents’ Delivery Against Lung Cancer: A Review
24 Oct 2025 14:10 GMT
… lung cancer into non-small cell lung cancer (NSCLC) and small cell lung cancer … of lung cancer.
Current treatment modalities for lung cancer include … CPT-NPs inhibited lung tumor growth by … N, Roberts CJ. Cetuximab-conjugated chitosan-pectinate (modified …
-
BBOT Reports Third Quarter 2025 Financial Results and Update on Corporate Progress
12 Nov 2025 21:05 GMT
… G12C mutant non-small cell lung cancer (“NSCLC”).
BBO-8520 has been … KRAS mutant non-small cell lung cancer.
Initial Phase 1 clinical data … benefit was also observed with cetuximab and anti-PD-1 treatment …
-
KRAS Inhibitors Market to Witness Explosive Growth at a CAGR of 35% During the Forecast Period (2025–2034) Amid Expanding Therapeutic Landscape | DelveInsight
12 Nov 2025 18:00 GMT
… Cancer, Non-small Cell Lung Cancer, Ovarian Cancer, Colorectal … Cancer, Non-small Cell Lung Cancer, Ovarian Cancer, Colorectal … -07934040, BAY3498264, KQB365 ± cetuximab, QTX3544, LUMAKRAS/LUMYKRAS … Cell Lung Cancer Market Non-small Cell Lung Cancer Market …
-
Lung Cancer Drugs Shows Promise for Treatment-Resistant Melanoma
11 Jun 2025 19:07 GMT
… and lung cancers. The researchers tested two drugs from this class, Erbitux (cetuximab) and …
-
Investigational MK-1084 Demonstrates Antitumor Activity in Phase I Trial for Colorectal and Non-Small Cell Lung Cancers
31 May 2025 01:07 GMT
… CRC) and non-small cell lung cancer (NSCLC). Across both patient … and in combination with cetuximab with or without chemotherapy … with non-small cell lung cancer. Based on early evidence … metastatic non-small cell lung cancer.”
Upcoming KANDLELIT-012 trial …
-
Merck Announces MK-1084, an Investigational KRAS G12C Inhibitor, Shows Antitumor Activity in Phase 1 Trial of Patients With Advanced Colorectal Cancer and Non-Small Cell Lung Cancer Whose Tumors Harbor KRAS G12C Mutations
30 May 2025 12:21 GMT
… CRC) and non-small cell lung cancer (NSCLC). In patients with … as in combination with cetuximab with or without chemotherapy … test.
Non-Small Cell Lung Cancer
KEYTRUDA, in combination with … metastatic nonsquamous non-small cell lung cancer (NSCLC), with no …
-
Phase 1/2 Trial Investigating ATR-04 for EGFRi-Related Rashes in Lung Cancer
28 May 2025 22:23 GMT
… patients with non-small cell lung cancer, colorectal cancer and others, … , such as non-small cell lung cancer, colorectal cancer, pancreatic cancer, …
EGFR inhibitors — including drugs like Erbitux (cetuximab), Vectibix (panitumumab), Tarceva (erlotinib) …
-
Personalizing Lung Cancer Treatment Reduces Toxicity and Improves Cure Rates
08 May 2025 14:25 GMT
… population.3
New lung cancer treatment options have … NSCLC. Chemotherapy-free lung cancer treatment would be … effective.
Advancing Personalized Lung Cancer Treatment
Chemotherapy can cause … cetuximab for unresectable stage III non-small-cell lung cancer. …
-
NANOBIOTIX Announces Presentation of Data From Two Phase 1 Studies Evaluating JNJ-1900 (NBTXR3) at the European Lung Cancer Conference
20 Mar 2025 20:15 GMT
… NBTXR3) for patients with lung cancer (NSCLC) to be … presented at the 2025 European Lung Cancer Conference (“ELCC”). ABSTRACT … Locoregional Recurrent Non-Small Cell Lung Cancer (“NSCLC”)
Saumil J. … therapy, with or without cetuximab, for the treatment …
-
Design, Synthesis and Evaluation of Novel Cyclopropanesulfonamide Derivatives for the Treatment of EGFRC797S Mutation in Non-Small Cell Lung Cancer
27 Feb 2025 05:59 GMT
… cell lung cancer (NSCLC) and small cell lung cancer.1,2 … was combined with cetuximab,26 it demonstrated inhibitory … G, Pelosi E. Lung cancers: molecular characterization, clonal heterogeneity … non-small cell lung cancer (NSCLC). Lung Cancer. 2019;137:113 …
About
© 1995-2025